Phenotype
|
Fish
|
Conditions
|
Figures
|
keratinocyte progenitor cell apoptotic process decreased rate, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 5
from Chen et al., 2021
|
head mdm2 expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
inner ear ionocyte atp6v1aa expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head cdkn3 expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head dhfr expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
inner ear NaK ionocyte atp1b2b expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head ccne1 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head cul3a expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
NaK ionocyte decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head cdk4 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head ab4-h2afx labeling increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 8
from Chen et al., 2021
|
head tp53 expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
otolith decreased area, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 2
from Chen et al., 2021
|
vH ionocyte decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head ab2-atr labeling increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 8
from Chen et al., 2021
|
inner ear vH ionocyte Ab6-atp6v1a labeling decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
startle response decreased process quality, abnormal
|
mafbahzu17/hzu17
|
vibration
|
Figure 3
from Chen et al., 2021
|
head foxa1 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
epidermal stem cell apoptotic process decreased rate, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 5
from Chen et al., 2021
|
vH ionocyte apoptotic process increased rate, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head mycb expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
epidermal stem cell ab1-tp63 labeling decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 4 ,
Figure 5
from Chen et al., 2021
|
head baxa expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
inner ear NaK ionocyte atp1b1a expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head cdkn1bb expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head cdk2 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head Ab2-mafba labeling decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 1
from Chen et al., 2021
|
ionocyte cell population proliferation decreased rate, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 4
from Chen et al., 2021
|
epidermal stem cell cell population proliferation decreased rate, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 4
from Chen et al., 2021
|
inner ear vH ionocyte atp6v1aa expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
ionocyte progenitor cell foxi3a expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 4
from Chen et al., 2021
|
inner ear ionocyte atp1a1a.4 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head mdm4 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head ccnd1 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head mafba expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 1
from Chen et al., 2021
|
head e2f1 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head Ab4-atm labeling increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 8
from Chen et al., 2021
|
otolith lumen increased area, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 2
from Chen et al., 2021
|
head cdkn1a expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
ionocyte progenitor cell dlc expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 4
from Chen et al., 2021
|
inner ear ionocyte atp1b2b expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head casp8 expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
NaK ionocyte apoptotic process increased rate, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
ionocyte apoptotic process decreased rate, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 5
from Chen et al., 2021
|
head bbc3 expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head rangap1a expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
ionocyte apoptotic process increased rate, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6 ,
Figure 8
from Chen et al., 2021
|
ionocyte progenitor cell foxi3b expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 4
from Chen et al., 2021
|
head bcl2a expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head tk1 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head e2f3 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head cdkn2a/b expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
inner ear ionocyte ab4-h2afx labeling increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 8
from Chen et al., 2021
|
inner ear NaK ionocyte atp1a1a.4 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head cul1a expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head rb1 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
keratinocyte progenitor cell cell population proliferation decreased rate, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 4
from Chen et al., 2021
|
inner ear ionocyte atp1b1a expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 6
from Chen et al., 2021
|
head cdk6 expression decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
head casp10 expression increased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
cell cycle phase transition decreased process quality, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 7
from Chen et al., 2021
|
ionocyte progenitor cell ab2-dlc labeling decreased amount, abnormal
|
mafbahzu17/hzu17
|
standard conditions
|
Figure 4 ,
Figure 5
from Chen et al., 2021
|
retinal rod cell EGFP expression decreased distribution, abnormal
|
mafbahzu17/+; nrlhzu16/hzu16; kj2Tg
|
standard conditions
|
Fig 8
from Liu et al., 2022
|
retinal rod cell decreased amount, abnormal
|
mafbahzu17/+; nrlhzu16/hzu16; kj2Tg
|
standard conditions
|
Fig 8
from Liu et al., 2022
|
retinal rod cell absence of anatomical entity, abnormal
|
mafbahzu17/hzu17; nrlhzu16/hzu16; kj2Tg
|
standard conditions
|
Fig 8
from Liu et al., 2022
|
retinal rod cell EGFP expression absent, abnormal
|
mafbahzu17/hzu17; nrlhzu16/hzu16; kj2Tg
|
standard conditions
|
Fig 8
from Liu et al., 2022
|
whole organism dead, abnormal
|
mafbahzu17/hzu17; nrlhzu16/hzu16; kj2Tg
|
standard conditions
|
text only
from Liu et al., 2022
|